A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Blackwell, K; Kaplan, EH; Franco, SX; Marcom, PK; Maleski, J; Sorensen, M; Berger, MS

Published Date

  • January 1, 2004

Published In

Volume / Issue

  • 15 /

Start / End Page

  • 27 - 27

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0923-7534